These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


718 related items for PubMed ID: 16234977

  • 1. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
    Viereck V, Gründker C, Friess SC, Frosch KH, Raddatz D, Schoppet M, Nisslein T, Emons G, Hofbauer LC.
    J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
    Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Gründker C, Hofbauer LC.
    Biochem Biophys Res Commun; 2002 Mar 01; 291(3):680-6. PubMed ID: 11855844
    [Abstract] [Full Text] [Related]

  • 3. Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts.
    Viereck V, Gründker C, Blaschke S, Niederkleine B, Siggelkow H, Frosch KH, Raddatz D, Emons G, Hofbauer LC.
    J Clin Endocrinol Metab; 2003 Sep 01; 88(9):4206-13. PubMed ID: 12970288
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
    Viereck V, Gründker C, Blaschke S, Frosch KH, Schoppet M, Emons G, Hofbauer LC.
    J Cell Biochem; 2005 Dec 15; 96(6):1244-53. PubMed ID: 16152630
    [Abstract] [Full Text] [Related]

  • 5. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts.
    Viereck V, Gründker C, Blaschke S, Siggelkow H, Emons G, Hofbauer LC.
    J Cell Biochem; 2002 Dec 15; 84(4):725-35. PubMed ID: 11835398
    [Abstract] [Full Text] [Related]

  • 6. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
    Humphrey EL, Williams JH, Davie MW, Marshall MJ.
    Bone; 2006 May 15; 38(5):652-61. PubMed ID: 16298558
    [Abstract] [Full Text] [Related]

  • 7. A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets.
    De Wilde A, Lieberherr M, Colin C, Pointillart A.
    J Cell Physiol; 2004 Aug 15; 200(2):253-62. PubMed ID: 15174095
    [Abstract] [Full Text] [Related]

  • 8. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.
    Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE.
    Bone; 2005 May 15; 36(5):812-9. PubMed ID: 15794927
    [Abstract] [Full Text] [Related]

  • 9. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.
    J Cell Physiol; 2005 Jun 15; 203(3):573-82. PubMed ID: 15573398
    [Abstract] [Full Text] [Related]

  • 10. Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells.
    Chen WF, Wong MS.
    Br J Nutr; 2006 Jun 15; 95(6):1039-47. PubMed ID: 16768824
    [Abstract] [Full Text] [Related]

  • 11. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T, Utsuyama M, Hirokawa K.
    J Bone Miner Res; 2001 Aug 15; 16(8):1416-25. PubMed ID: 11499864
    [Abstract] [Full Text] [Related]

  • 12. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.
    Hofbauer LC, Shui C, Riggs BL, Dunstan CR, Spelsberg TC, O'Brien T, Khosla S.
    Biochem Biophys Res Commun; 2001 Jan 12; 280(1):334-9. PubMed ID: 11162519
    [Abstract] [Full Text] [Related]

  • 13. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H, Härkönen PL, Väänänen HK, Hentunen TA.
    J Bone Miner Res; 2005 Dec 12; 20(12):2224-32. PubMed ID: 16294275
    [Abstract] [Full Text] [Related]

  • 14. PTH differentially regulates expression of RANKL and OPG.
    Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA.
    J Bone Miner Res; 2004 Feb 12; 19(2):235-44. PubMed ID: 14969393
    [Abstract] [Full Text] [Related]

  • 15. Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like cells.
    Maddi A, Hai H, Ong ST, Sharp L, Harris M, Meghji S.
    Bone; 2006 Aug 12; 39(2):283-8. PubMed ID: 16567138
    [Abstract] [Full Text] [Related]

  • 16. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS, Rettmer E, Eriksen EF, Hegedüs L, Beck-Nielsen H, Abrahamsen B.
    Bone; 2004 Jul 12; 35(1):256-65. PubMed ID: 15207766
    [Abstract] [Full Text] [Related]

  • 17. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov 12; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT.
    J Bone Miner Res; 2001 Oct 12; 16(10):1787-94. PubMed ID: 11585342
    [Abstract] [Full Text] [Related]

  • 19. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM, Lee YS, Byun CH, Chang EJ, Kim H, Kim YH, Kim HH, Kim GS.
    J Endocrinol; 2005 Jun 12; 185(3):401-13. PubMed ID: 15930166
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK, Lorenzo JA.
    Endocrinology; 1999 Aug 12; 140(8):3552-61. PubMed ID: 10433211
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.